CCDR: Volume 46-4 -April 2020: Respiratory syncytial virus (RSV)
The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
- Publisher
- Public Health Agency of Canada
- Resources
- 36
- Catalogue metadata updated
- 2020-04-06
Data overview
- Formats
- HTML, PDF
- File languages
- English, French
Official sources and licences
Resources
- CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) (French, HTML) HTML
- CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) (French, PDF) PDF
- CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) (English, PDF) PDF
- CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) (English, HTML) HTML
- Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) (French, PDF) PDF
- Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) (English, HTML) HTML
- Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) (French, HTML) HTML
- Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) (English, PDF) PDF
- Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat (French, HTML) HTML
- Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat (English, PDF) PDF
- Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat (French, PDF) PDF
- Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat (English, HTML) HTML
- Infographic: Summary of RSV vaccine products in late-stage development (English, HTML) HTML
- Infographic: Summary of RSV vaccine products in late-stage development (English, PDF) PDF
- Infographic: Summary of RSV vaccine products in late-stage development (French, PDF) PDF
- Infographic: Summary of RSV vaccine products in late-stage development (French, HTML) HTML
- Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 (English, HTML) HTML
- Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 (French, PDF) PDF
- Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 (English, PDF) PDF
- Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 (French, HTML) HTML
- Measles surveillance in Canada: 2018 (French, PDF) PDF
- Measles surveillance in Canada: 2018 (French, HTML) HTML
- Measles surveillance in Canada: 2018 (English, PDF) PDF
- Measles surveillance in Canada: 2018 (English, HTML) HTML
- Motivational interviewing: A powerful tool to address vaccine hesitancy (English, HTML) HTML
- Motivational interviewing: A powerful tool to address vaccine hesitancy (French, HTML) HTML
- Motivational interviewing: A powerful tool to address vaccine hesitancy (English, PDF) PDF
- Motivational interviewing: A powerful tool to address vaccine hesitancy (French, PDF) PDF
- Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada (English, HTML) HTML
- Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada (French, PDF) PDF
- Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada (French, HTML) HTML
- Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada (English, PDF) PDF
- Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 (English, HTML) HTML
- Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 (French, PDF) PDF
- Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 (English, PDF) PDF
- Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 (French, HTML) HTML